Beta Amyloid News and Research

RSS

Magnetic susceptibility as a promising marker for predicting future severity of Parkinson's disease

Researchers evaluate quantitative magnetic susceptibility mapping in detecting quantifiable markers of Parkinson’s disease progression.

18 Jul 2023

Donanemab may offer new hope for people with early Alzheimer's disease

The data reported today by Eli Lilly from the TRAILBLAZER-ALZ 2 clinical trial of donanemab in early symptomatic Alzheimer's disease demonstrate an important advancement in Alzheimer's research and treatment.

17 Jul 2023

Resistance training could be a simple and affordable therapy for Alzheimer's patients

Regular physical exercise, such as resistance training, can prevent Alzheimer's disease, or at least delay the appearance of symptoms, and serves as a simple and affordable therapy for Alzheimer's patients.

3 Jul 2023

Connecting the inflammatory dots: Obesity, depression, and Alzheimer's linked by neuroinflammation

Obesity-induced neuroinflammation significantly contributes to the pathophysiology of depression and Alzheimer's disease. Targeting midlife stage for intervention is crucial to potentially prevent Alzheimer's pathology.

13 Jun 2023

A deep slumber may help buffer Alzheimer’s-related memory issues

A deep slumber might help buffer against memory loss for older adults facing a heightened burden of Alzheimer's disease, new research from the University of California, Berkeley, suggests.

4 May 2023

A scientific statement from the American Heart and Stroke Association on the prevalence, diagnosis, and management of poststroke cognitive impairment

Researchers reviewed the incidence, prevalence, diagnosis, and management of post-stroke cognitive impairment.

3 May 2023

Study finds no association between gout and neurodegenerative diseases in the general population

A study published in Scientific Reports highlights that gout can increase the risk of Alzheimer’s disease and Parkinson’s disease in younger or overweight individuals. The study was conducted in a representative Korean population.

8 Mar 2023

The natural history of tau accumulation and the impact of disease stage and reference region on the magnitude and effect size of regional change

Researchers performed serial tau imaging with 18F-MK6240 to detect tau accumulation in cognitively unimpaired beta-amyloid negative Alzheimer’s disease patients as well as those with mild cognitive impairment who were Aβ+ at baseline.

27 Feb 2023

Major funding boost for research on neurodegenerative diseases

Brain Canada and the Canadian Institutes of Health Research congratulate Dr. Meaghan O'Reilly from Sunnybrook Research Institute and the University of Toronto as well as Dr. Liang Li based out of University of Alberta whose projects have been recommended for funding as part the 2022 European Union Joint Programme on Neurodegenerative Disease Research (JPND)'s initiative to find causes, develop cures and identify better ways to care for people with Alzheimer's, Parkinson's, Huntington's and other neurodegenerative diseases more rapidly.

16 Feb 2023

Novel nuclear medicine imaging protocol cuts costs and radiation exposure for Alzheimer's patients

A novel nuclear medicine imaging protocol can take the place of two separate imaging scans for the evaluation of brain changes linked to cognitive impairment, cutting costs and radiation exposure for patients as well as providing them greater comfort.

8 Feb 2023

Blood-based markers could lead to earlier detection of Alzheimer's disease

Alzheimer's disease begins decades before any symptoms, such as memory loss, start to show. Consequently, early diagnosis increases the chances of slowing the disease down with drugs.

10 Jan 2023

Targeting defective tau proteins may be needed to treat Alzheimer’s patients

In November, researchers reported the drug lecanemab slowed the progression of Alzheimer's disease. The effect was modest, but it has generated tremendous excitement because it was the first time a drug had been shown to be able to affect the course of this relentless, incurable disease.

26 Dec 2022

Activation of microglial cells can slow down Alzheimer's progression

The brain's big-eating immune cells can slow down the progression of Alzheimer's disease. This is shown by a study that is now published in Nature Aging.

29 Nov 2022

People with Alzheimer's disease can be identified before any symptoms appear

A large study led by Lund University in Sweden has shown that people with Alzheimer's disease can now be identified before they experience any symptoms.

11 Nov 2022

Green tea catechins and resveratrol display neuroprotective properties in Alzheimer's models

In a recent study published in the journal Free Radical Biology and Medicine, researchers screened for neuroprotective compounds against Alzheimer’s disease (AD).

3 Nov 2022

First-of-its-kind computer model simulates a clinical trial evaluating two Alzheimer’s drugs

An estimated 6.2 million Americans ages 65 and older are living with Alzheimer's disease. The national Alzheimer's Association predicts that number to grow to 13.8 million by 2060, barring the development of medical breakthroughs that would prevent, slow or cure the debilitating disease.

2 Nov 2022

Beta Amyloid News and Research

Magnetic susceptibility as a promising marker for predicting future severity of Parkinson's disease

Donanemab may offer new hope for people with early Alzheimer's disease

Resistance training could be a simple and affordable therapy for Alzheimer's patients

Connecting the inflammatory dots: Obesity, depression, and Alzheimer's linked by neuroinflammation

A deep slumber may help buffer Alzheimer’s-related memory issues

A scientific statement from the American Heart and Stroke Association on the prevalence, diagnosis, and management of poststroke cognitive impairment

Study finds no association between gout and neurodegenerative diseases in the general population

The natural history of tau accumulation and the impact of disease stage and reference region on the magnitude and effect size of regional change

Major funding boost for research on neurodegenerative diseases

Novel nuclear medicine imaging protocol cuts costs and radiation exposure for Alzheimer's patients

Blood-based markers could lead to earlier detection of Alzheimer's disease

Targeting defective tau proteins may be needed to treat Alzheimer’s patients

Activation of microglial cells can slow down Alzheimer's progression

People with Alzheimer's disease can be identified before any symptoms appear

Green tea catechins and resveratrol display neuroprotective properties in Alzheimer's models

First-of-its-kind computer model simulates a clinical trial evaluating two Alzheimer’s drugs

Discovery could affect the search for new Alzheimer's drugs

Low meal frequency is suggested to decrease Alzheimer’s disease risk

The role of oxidative stress in congenital syndromes

Microscopy technique enables visualization of unseen nanostructures within cells and tissues

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News